Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Sera Prognostics, Inc.

SERANASDAQ
Healthcare
Medical - Diagnostics & Research
$2.57
$0.00(0.00%)
U.S. Market is Open • 12:53

Sera Prognostics, Inc. Fundamental Analysis

Sera Prognostics, Inc. (SERA) shows weak financial fundamentals with a PE ratio of -3.83, profit margin of -343.43%, and ROE of -41.70%. The company generates $0.0B in annual revenue with weak year-over-year growth of -74.84%.

Key Strengths

Cash Position34.84%
PEG Ratio-0.41
Current Ratio1.89

Areas of Concern

ROE-41.70%
Operating Margin-389.19%
We analyze SERA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -25845.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-25845.5/100

We analyze SERA's fundamental strength across five key dimensions:

Efficiency Score

Weak

SERA struggles to generate sufficient returns from assets.

ROA > 10%
-30.17%

Valuation Score

Excellent

SERA trades at attractive valuation levels.

PE < 25
-3.83
PEG Ratio < 2
-0.41

Growth Score

Moderate

SERA shows steady but slowing expansion.

Revenue Growth > 5%
-74.84%
EPS Growth > 10%
14.66%

Financial Health Score

Excellent

SERA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
1.89

Profitability Score

Weak

SERA struggles to sustain strong margins.

ROE > 15%
-4169.54%
Net Margin ≥ 15%
-343.43%
Positive Free Cash Flow
No

Key Financial Metrics

Is SERA Expensive or Cheap?

P/E Ratio

SERA trades at -3.83 times earnings. This suggests potential undervaluation.

-3.83

PEG Ratio

When adjusting for growth, SERA's PEG of -0.41 indicates potential undervaluation.

-0.41

Price to Book

The market values Sera Prognostics, Inc. at 1.52 times its book value. This may indicate undervaluation.

1.52

EV/EBITDA

Enterprise value stands at -3.04 times EBITDA. This is generally considered low.

-3.04

How Well Does SERA Make Money?

Net Profit Margin

For every $100 in sales, Sera Prognostics, Inc. keeps $-343.43 as profit after all expenses.

-343.43%

Operating Margin

Core operations generate -389.19 in profit for every $100 in revenue, before interest and taxes.

-389.19%

ROE

Management delivers $-41.70 in profit for every $100 of shareholder equity.

-41.70%

ROA

Sera Prognostics, Inc. generates $-30.17 in profit for every $100 in assets, demonstrating efficient asset deployment.

-30.17%

Following the Money - Real Cash Generation

Operating Cash Flow

Sera Prognostics, Inc. generates limited operating cash flow of $-19.57M, signaling weaker underlying cash strength.

$-19.57M

Free Cash Flow

Sera Prognostics, Inc. generates weak or negative free cash flow of $-19.92M, restricting financial flexibility.

$-19.92M

FCF Per Share

Each share generates $-0.53 in free cash annually.

$-0.53

FCF Yield

SERA converts -27.87% of its market value into free cash.

-27.87%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.83

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.41

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

998.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.42

vs 25 benchmark

ROA

Return on assets percentage

-0.30

vs 25 benchmark

ROCE

Return on capital employed

-0.44

vs 25 benchmark

How SERA Stacks Against Its Sector Peers

MetricSERA ValueSector AveragePerformance
P/E Ratio-3.8329.43 Better (Cheaper)
ROE-41.70%800.00% Weak
Net Margin-34343.16%-20145.00% (disorted) Weak
Debt/Equity0.030.30 Strong (Low Leverage)
Current Ratio1.894.64 Neutral
ROA-30.17%-17936.00% (disorted) Weak

SERA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sera Prognostics, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

16.81%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

12.10%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

59.90%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ